Activity and structure of human acetyl‐CoA carboxylase targeted by a specific inhibitor

• Published in: FEBS letters Vol. 592; no. 12; pp. 2048 - 2058
• Main Authors: Jang, SoRi, Gornicki, Piotr, Marjanovic, Jasmina, Bass, Ethan, P. Iurcotta, Toni, Rodriguez, Pedro, Austin, Jotham, Haselkorn, Robert
• Format: Journal Article
• Language: English
• Published: England 01.06.2018
• Subjects: acetyl‐CoA carboxylase; binding site; human; inhibitor; inhibitor; acetyl-CoA carboxylase; human; binding site
• ISSN: 0014-5793; 1873-3468
• DOI: 10.1002/1873-3468.13097

We have studied a series of human acetyl‐CoA carboxylase (ACC) 1 and ACC2 proteins with deletions and/or Ser to Ala substitutions of the known phosphorylation sites. In vitro dephosphorylation/phosphorylation experiments reveal a substantial level of phosphorylation of human ACCs produced in insect cells. Our results are consistent with AMPK phosphorylation of Ser29, Ser80, Ser1,201, and Ser1,216. Phosphorylation of the N‐terminal regulatory domain decreases ACC1 activity, while phosphorylation of residues in the ACC central domain has no effect. Inhibition of the activity by phosphorylation is significantly more profound at citrate concentrations below 2 mm. Furthermore, deletion of the N‐terminal domain facilitates structural changes induced by citrate, including conversion of ACC dimers to linear polymers. We have also identified ACC2 amino acid mutations affecting specific inhibition of the isozyme by compound CD‐017‐0191. They form two clusters separated by 60–90 Å: one located in the vicinity of the BC active site and the other one in the vicinity of the ACC1 phosphorylation sites in the central domain, suggesting a contribution of the interface of two ACC dimers in the polymer to the inhibitor binding site.